Menu Search
Equities

Prenetics Global Ltd

PRE:NMQ

Prenetics Global Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)4.60
  • Today's Change0.17 / 3.84%
  • Shares traded12.83k
  • 1 Year change-12.38%
  • Beta-0.1811
Data delayed at least 15 minutes, as of Nov 08 2024 20:46 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Prenetics Global Ltd grew revenues 65.17% from 13.16m to 21.74m while net income improved from a loss of 190.45m to a smaller loss of 62.72m.
Gross margin52.31%
Net profit margin-211.67%
Operating margin-199.61%
Return on assets-18.52%
Return on equity-22.62%
Return on investment-22.89%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Prenetics Global Ltd fell by 100.95m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 13.76m for operations while cash used for investing totalled 82.95m.
Cash flow per share-3.46
Price/Cash flow per share--
Book value per share17.70
Tangible book value per share13.78
More ▼

Balance sheet in USDView more

Prenetics Global Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 1.22%.
Current ratio2.06
Quick ratio1.98
Total debt/total equity0.0126
Total debt/total capital0.0122
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.